[Electroencephalographic changes and antitubercular treatments].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects*; D004347:Drug Interactions; D004569:Electroencephalography; D004977:Ethambutol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects; D012737:Sex Factors; D013307:Streptomycin / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D004977:Ethambutol; D000410:Alanine Transaminase; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Altérations électro-encéphalographiques et traitements antituberculeux.